Skip to content
2000
Volume 30, Issue 6
  • ISSN: 1385-2728
  • E-ISSN: 1875-5348

Abstract

Triazine is a heterocyclic aromatic ring that is divided into three isomers by nitrogen atom positions. 2-Aza-2-desamino-5,8-dideazafolic acid and 2-azaadenosine are 1,2,3-triazine derivatives, whereas azaribine, tirapazamine, lamotrigine, and 6-azacytosine are 1,2,4-triazine derivatives. Natural antibiotics like fervenulin, reumycin, and toxoflavin have a triazine ring structure. Ammeline, aceto-guanide, acetoguanamine, cyanuric acid, and melamine all include 1,3,5-triazine isomer or s-triazine as a lead structure. Hexamethylmelamine (altretamine), atrazine, cycloguanil, and almitrine are examples of s-triazine-containing medications. Triazines are important in pharmaceutical chemistry because they exhibit a wide range of pharmacological actions, making them valuable for drug design and development. Some triazine analogs have recently been tested in clinical trials, which might lead to more powerful medications and have fewer adverse effects than currently available pharmaceuticals. This article discusses the biological significance and synthesis of several triazine derivatives derived from heterocyclic and Triazine-containing medicines.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/coc/10.2174/0113852728379266250708074432
2025-07-30
2026-02-28

  • From This Site

    /content/journals/coc/10.2174/0113852728379266250708074432
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. KumarR. KumarN. RoyR.K. SinghA. Triazines – A comprehensive review of their synthesis and diverse biological importance.Curr. Med. Drug Res.20171139
     [Google Scholar]
  2. KhalilE.G. BerghotM. GoudaM. Design, synthesis and antibacterial activity of new phthalazinedione derivatives.J. Serb. Chem. Soc.201176332933910.2298/JSC091122028K
     [Google Scholar]
  3. Majeed GanaiA. Khan PathanT. HampannavarG.A. PawarC. ObakachiV.A. KushwahaB. Deshwar KushwahaN. KarpoormathR. Recent advances on the s‐triazine scaffold with emphasis on synthesis, structure‐activity and pharmacological aspects: A concise review.ChemistrySelect2021671616166010.1002/slct.202004591
     [Google Scholar]
  4. ButlerR.N. FahyA.M. FoxA. StephensJ.C. McArdleP. CunninghamD. RyderA.G. New reactive fluorophores in the 1,2,3-triazine series.Tetrahedron Lett.200647111721172410.1016/j.tetlet.2006.01.052
     [Google Scholar]
  5. MontgomeryJ.A. ThomasH.J. Nucleosides of 2-azapurines and certain ring analogs.J. Med. Chem.197215218218710.1021/jm00272a014 4536650
     [Google Scholar]
  6. RoeowskyA ForschRA Morant RG 3-(acetylamino)-2,4-pentanedione, 5440-23-3; 4-acetyl-2,5-dimethoxazole, 23000-12-6; 3-(4-nitro-phenoxy) propionic acid, 10572-16-4; a-aminopropiophenone hy-drochloride, 16735 19-6; a.aminopropiophenone hy-drochloride199235
     [Google Scholar]
  7. KumarR. SinghAD. SinghJ. SinghH. RoyRK. ChaudharyA. 1,2,3-Triazine scaffold as a potent biologically active moiety: A mini review.Mini Rev. Med. Chem.2014141728310.2174/1389557513666140103111017
     [Google Scholar]
  8. CascioferroS. ParrinoB. SpanòV. CarboneA. MontalbanoA. BarrajaP. DianaP. CirrincioneG. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.Eur. J. Med. Chem.201714232837510.1016/j.ejmech.2017.08.009 28851503
     [Google Scholar]
  9. MahindraA. JenkinsL. MarsangoS. HuggettM. HuggettM. RobinsonL. GillespieJ. RajamanickamM. MorrisonA. McElroyS. TikhonovaI.G. MilliganG. JamiesonA.G. Investigating the structure–activity relationship of 1,2,4-triazine g-protein-coupled receptor 84 (GPR84) antagonists.J. Med. Chem.20226516112701129010.1021/acs.jmedchem.2c00804 35948061
     [Google Scholar]
  10. KumarR. SirohiT.S. SinghH. YadavR. RoyR.K. ChaudharyA. PandeyaS.N. 1,2,4-triazine analogs as novel class of therapeutic agents.Mini Rev. Med. Chem.201414216820710.2174/1389557514666140131111837 24479860
     [Google Scholar]
  11. SułkowskaA. RównickaJ. BojkoB. SułkowskiW. Interaction of anticancer drugs with human and bovine serum albumin.J. Mol. Struct.2003651-65313314010.1016/S0022‑2860(02)00642‑7
     [Google Scholar]
  12. SteffenE. WiedemannS. GeorgieffM. Combined intravenous administration of diclofenac and apazone for postoperative analgesia A randomized study of 112 patients with access to i. v. on-demand analgesia after minor orthopaedic operations.Schmerz19948423524210.1007/BF02527892 18415463
     [Google Scholar]
  13. GazievaGA. PoluboyarovPA. NelyubinaYV. StruchkovaMI. Kravchenko, AN Synthesis of imidazo[4,5-e][1,3]thiazolo-[3,2-b][1,2,4]triazines.Chem. Heterocycl. Compd.2012481382138910.1007/s10593‑012‑1147‑3
     [Google Scholar]
  14. GoaK.L. RossS.R. ChrispP. Lamotrigine.Drugs199346115217610.2165/00003495‑199346010‑00009 7691504
     [Google Scholar]
  15. SarkarU. GlaserR. ParsonsZ.D. BarnesC.L. GatesK.S. Synthesis, crystal structure, and rotational energy profile of 3-cyclopropyl-1,2,4-benzotriazine 1,4-di-n-oxide.J. Chem. Crystallogr.201040762462910.1007/s10870‑010‑9707‑9 22294856
     [Google Scholar]
  16. KrečmerováM. OtmarM. 5-azacytosine compounds in medicinal chemistry: Current stage and future perspectives.Future Med. Chem.201248991100510.4155/fmc.12.36 22650240
     [Google Scholar]
  17. HeB. ZhouH. Theoretical study on drum-shaped polymers (1,3,5-Triazine) 2 ncomposed of nonplanar π-extended polymerization units.ACS Omega2020520116181162810.1021/acsomega.0c00850 32478252
     [Google Scholar]
  18. SafinD.A. Structural and in silico studies of 2-pyridyl-decorated 2-amino-1,3,5-triazine with a potency against SARS-CoV-2 proteins.C. R. Chim.202427G115316610.5802/crchim.290
     [Google Scholar]
  19. ViswanathaG.L. PriyadarshiniB.J. KrishnadasN. JanardhananS. RangappaS. HanumanthappaS. Synthesis and antihistaminic activity of 3H-benzo[4,5] thieno[2,3-d][1,2,3] triazin-4-ones.Saudi Pharm. J.2012201455210.1016/j.jsps.2011.05.005 24109203
     [Google Scholar]
  20. YeoA.E.T. EdsteinM.D. ShanksG.D. RieckmannK.H. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.Ann. Trop. Med. Parasitol.199488658759410.1080/00034983.1994.11812909 7893172
     [Google Scholar]
  21. DhainautA. RegnierG. TizotA. PierreA. LeonceS. GuilbaudN. New purines and purine analogs as modulators of multidrug resistance.J. Med. Chem.199639204099410810.1021/jm960361i 8831775
     [Google Scholar]
  22. TomassettiM. MartiniE. CampanellaL. FaveroG. SanzóG. MazzeiF. A new surface plasmon resonance immunosensor for triazine pesticide determination in bovine milk: A comparison with conventional amperometric and screen-printed immunodevices.Sensors2015155102551027010.3390/s150510255 25942643
     [Google Scholar]
  23. HansenL.A. HughesT.E. Altretamine.DICP199125214615210.1177/106002809102500209 1905441
     [Google Scholar]
  24. SidwellR.W. DixonG.J. SellersS.M. SchabelF.M. In vivo antiviral properties of biologically active compounds II Studies with influenza and vaccinia virusesAppl Microbiol.196816237039210.1128/am.16.2.370‑392.1968 5694419
     [Google Scholar]
  25. GabrielsenB. KirsiJ.J. KwongC.D. CarterD.A. KrauthC.A. HannaL.K. In vitro and in vivo antiviral (RNA) evaluation of orotidine 5′-monophosphate decarboxylase inhibitors and analogues including 6-azauridine-5′-(ethyl methoxyalaninyl)phosphate (a 5′-monophosphate prodrug).Antivir. Chem. Chemother.19945420922010.1177/095632029400500402
     [Google Scholar]
  26. SteffenhagenK.A. EasterdayB.C. GalassoG.J. Friedman-KienA. KleinR.J. KernE.R. Evaluation of 6-azauridine and s-iododeoxyuridine in the treatment of experimental viral infections.J. Infect. Dis.1976133660361210.1093/infdis/133.6.603 180189
     [Google Scholar]
  27. KarnofskyD.A. Triethylene melamine in the treatment of lymphomas and leukemias.Med. Clin. North Am.195438254155410.1016/S0025‑7125(16)34896‑9 13153527
     [Google Scholar]
  28. MilesS. xPharm: The comprehensive pharmacology reference; Elsevier,200715
     [Google Scholar]
  29. VoglerW.R. OlanskyS. A double-blind study of azaribine in the treatment of psoriasis.Ann. Intern. Med.197073695195610.7326/0003‑4819‑73‑6‑951 4947943
     [Google Scholar]
  30. RichardsD.M. HeelR.C. BrogdenR.N. SpeightT.M. AveryG.S. LaceyR.W. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.Drugs198427646952710.2165/00003495‑198427060‑00001 6329638
     [Google Scholar]
  31. MessenheimerJ.A. Lamotrigine.Epilepsia199536s2S87S9410.1111/j.1528‑1157.1995.tb06002.x 8784217
     [Google Scholar]
  32. AusbornJ. WolfH. MaderW. KayserH. The insecticide pymetrozine selectively affects chordotonal mechanoreceptors.J. Exp. Biol.2005208234451446610.1242/jeb.01917 16339866
     [Google Scholar]
  33. PorstH. RosenR. Padma-NathanH. GoldsteinI. GiulianoF. UlbrichE. BandelT. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: The first at-home clinical trial.Int. J. Impot. Res.200113419219910.1038/sj.ijir.3900713 11494074
     [Google Scholar]
  34. Saas-TorresJ. DomingoC. MorónA. RuéM. MarínA. Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.Respir. Med.200397659960510.1053/rmed.2003.1486 12814142
     [Google Scholar]
  35. KeldsenN. HavsteenH. VergoteI. BertelsenK. JakobsenA. Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: A phase II study.Gynecol. Oncol.200388211812210.1016/S0090‑8258(02)00103‑8 12586589
     [Google Scholar]
  36. D’RuizC.D. PlautzJ.R. SchuetzR. SanabriaC. HammondsJ. EratoC. KlockJ. VollhardtJ. MesarosS. Preliminary clinical pharmacokinetic evaluation of bemotrizinol - A new sunscreen active ingredient being considered for inclusion under FDA’s over-the-counter (OTC) sunscreen monograph.Regul. Toxicol. Pharmacol.202313910534410.1016/j.yrtph.2023.105344 36738872
     [Google Scholar]
  37. WoodyR.C. KearnsG.L. BrewsterM.A. TurleyC.P. SharpG.B. LakeR.S.W.E. The neurotoxicity of cyclotrimethylenetrinitramine (RDX) in a child: A clinical and pharmacokinetic evaluation.J. Toxicol. Clin. Toxicol.198624430531910.3109/15563658608992595 3746987
     [Google Scholar]
  38. WatkinsW.M. SixsmithD.G. ChulayJ.D. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodiumfalciparum in vitro.Ann. Trop. Med. Parasitol.198478327327810.1080/00034983.1984.11811816 6385887
     [Google Scholar]
  39. HuthmacherK. MostD. Cyanuric Acid and Cyanuric Chloride. In: Ullmann’s Encyclopedia of Industrial Chemistry.Wiley200010.1002/14356007.a08_191
     [Google Scholar]
  40. Van De WouwA.P. BatterhamP. DabornP.J. The insect growth regulator insecticide cyromazine causes earlier emergence in Drosophila melanogaster.Arch. Insect Biochem. Physiol.200663310110910.1002/arch.20146 17048245
     [Google Scholar]
  41. BespalovV.G. KireevaG.S. BelyaevaO.A. KalininO.E. SenchikK.Y. StukovA.N. GaftonG.I. GuseynovK.D. BelyaevA.M. Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model.J. Surg. Oncol.2016113443844210.1002/jso.24140 26710749
     [Google Scholar]
  42. HerzogB. WehrleM. QuassK. Photostability of UV absorber systems in sunscreens.Photochem. Photobiol.200985486987810.1111/j.1751‑1097.2009.00544.x 19320846
     [Google Scholar]
  43. ColeyH.M. BrooksN. PhillipsD.H. HewerA. JenkinsT.C. JarmanM. The role of the N-(hydroxymethyl)melamines as antitumour agents: Mechanism of action studies.Biochem. Pharmacol.19954991203121210.1016/0006‑2952(95)00040‑7 7763301
     [Google Scholar]
  44. SączewskiF. BułakowskaA. BednarskiP. GrunertR. Synthesis, structure and anticancer activity of novel 2,4-diamino-1,3,5-triazine derivatives.Eur. J. Med. Chem.200641221922510.1016/j.ejmech.2005.10.013 16377034
     [Google Scholar]
  45. SteverdingD. The development of drugs for treatment of sleeping sickness: A historical review.Parasit. Vectors201031510.1186/1756‑3305‑3‑15 20219092
     [Google Scholar]
  46. SavadelisM.D. DayK.M. BradnerJ.L. WolstenholmeA.J. DzimianskiM.T. MoorheadA.R. Efficacy and side effects of doxycycline versus minocycline in the three-dose melarsomine canine adulticidal heartworm treatment protocol.Parasit. Vectors201811167110.1186/s13071‑018‑3264‑z 30587225
     [Google Scholar]
  47. ZhangJ.J. WangY.K. ZhouJ.H. XieF. GuoQ.N. LuF.F. JinS.F. ZhuH.M. YangH. Reduced phytotoxicity of propazine on wheat, maize and rapeseed by salicylic acid.Ecotoxicol. Environ. Saf.2018162425010.1016/j.ecoenv.2018.06.068 29960913
     [Google Scholar]
  48. CapelP.D. SpexetA.H. LarsonS.J. Occurrence and behavior of the herbicide Prometon in the hydrologic system.Environ. Sci. Technol.199933567468010.1021/es9807340
     [Google Scholar]
  49. CrowleyP.J. Use as agrochemicals Comprehensive heterocyclic chemistry.Amsterdam, NetherlandsElsevier198418519910.1016/B978‑008096519‑2.00007‑2
     [Google Scholar]
  50. ĐikićD. Prometryn. In: Encyclopedia of Toxicology.Elsevier20141077108110.1016/B978‑0‑12‑386454‑3.00533‑9
     [Google Scholar]
  51. BroserM. GlöcknerC. GabdulkhakovA. GuskovA. BuchtaJ. KernJ. MühF. DauH. SaengerW. ZouniA. Structural basis of cyanobacterial photosystem II Inhibition by the herbicide terbutryn.J. Biol. Chem.201128618159641597210.1074/jbc.M110.215970 21367867
     [Google Scholar]
  52. Management of triazine-resistant pigweed and lambsquarters. 2017. Available from: https://extension.psu.edu/management-of-triazine-resistant-pigweed-and-lambsquarters
  53. NyströB. BlanckH. Effects of the sulfonylurea herbicide metsulfuron methyl on growth and macromolecular synthesis in the green alga Selenastrum capricornutum.Aquat. Toxicol.1998431253910.1016/S0166‑445X(97)00093‑3
     [Google Scholar]
  54. EstradaM.H. InsuastyH. CucaL.E. MarderM. FierroA. GuerreroM.F. Anticonvulsant profile of 2-ethylthio-7-methyl-4-(4-methylphenyl)pyrazolo[1,5-a][1,3,5]triazine.Braz J. Pharm. Sci.2014501738110.1590/S1984‑82502011000100007
     [Google Scholar]
  55. HuangH. GuoW. WuW. LiC.J. JiangH. Copper-catalyzed oxidative C(sp 3)–H functionalization for facile synthesis of 1,2,4-triazoles and 1,3,5-triazines from amidines.Org. Lett.201517122894289710.1021/acs.orglett.5b00995 26023708
     [Google Scholar]
  56. YouQ. WangF. WuC. ShiT. MinD. ChenH. ZhangW. Synthesis of 1,3,5-triazines via Cu(OAc) 2 -catalyzed aerobic oxidative coupling of alcohols and amidine hydrochlorides.Org. Biomol. Chem.201513246723672710.1039/C5OB00724K 25991063
     [Google Scholar]
  57. IrannejadH. NadriH. NaderiN. RezaeianS.N. ZafariN. ForoumadiA. AminiM. KhoobiM. Anticonvulsant activity of 1,2,4-triazine derivatives with pyridyl side chain: Synthesis, biological, and computational study.Med. Chem. Res.20152462505251310.1007/s00044‑014‑1315‑3
     [Google Scholar]
  58. MoustafaM.S. MekheimerR.A. Al-MousawiS.M. Abd-ElmonemM. El-ZorbaH. HameedA.M.A. MohamedT.M. SadekK.U. Microwave-assisted efficient one-pot synthesis of N2 -(tetrazol-5-yl)-6-aryl/heteroaryl-5,6-dihydro-1,3,5-triazine-2,4-diamines.Beilstein J. Org. Chem.2020161706171210.3762/bjoc.16.142 32733614
     [Google Scholar]
  59. JunaidA. LimF.P.L. TiekinkE.R.T. DolzhenkoA.V. Design, synthesis, and biological evaluation of new 6, N2 -diaryl-1,3,5-triazine-2,4-diamines as anticancer agents selectively targeting triple negative breast cancer cells.RSC Advances20201043255172552810.1039/D0RA04970K 35518627
     [Google Scholar]
  60. ElieJ. FruitC. BessonT. Microwave-assisted sequential one-pot synthesis of 8-substituted pyrazolo[1,5-a][1,3,5]triazines.Molecules20212612354010.3390/molecules26123540 34200623
     [Google Scholar]
  61. KangG.F. ZhangG. One-pot synthesis of 1,3,5-triazine-2,4-dithione derivatives via three-component reactions.Beilstein J. Org. Chem.2020161447145510.3762/bjoc.16.120 32647546
     [Google Scholar]
  62. Ghorbani-VagheiR. ShahriariA. SalimiZ. HajinazariS. Solvent-free synthesis of triazines using N-halosulfonamides.RSC Advances2015553665366910.1039/C4RA10892B
     [Google Scholar]
  63. HerreraA. RiañoA. MorenoR. CasoB. PardoZ.D. FernándezI. SáezE. MoleroD. Sánchez-VázquezA. Martínez-AlvarezR. One-pot synthesis of 1,3,5-triazine derivatives via controlled cross-cyclotrimerization of nitriles: A mechanism approach.J. Org. Chem.201479157012702410.1021/jo501144v 25010006
     [Google Scholar]
  64. JunaidA. TanY.S. TiekinkE.R.T. DolzhenkoA.V. DolzhenkoA.V. JunaidA. A one-pot synthesis of N2, 6-diaryl-5,6-dihydro-1,3,5-triazine-2,4-diamines and systematic evaluation of their ability to host ethanol in crystals.RSC Advances2019964376603766710.1039/C9RA08795H 35542265
     [Google Scholar]
  65. YavariI. MosaferiS. A one-pot synthesis of 2H-pyrido[1,2-a][1,3,5]triazine-2-selenones from acyl isoselenocyanates and pyridin-2-amine.Monatsh. Chem.2017148596396610.1007/s00706‑016‑1834‑3
     [Google Scholar]
  66. SunL. BeraH. ChuiW.K. Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase.Eur. J. Med. Chem.20136511110.1016/j.ejmech.2013.03.063 23688695
     [Google Scholar]
  67. AhujaP. SiddiquiN. Anticonvulsant evaluation of clubbed indole-1,2,4-triazine derivatives: A synthetic approach.Eur. J. Med. Chem.20148050952210.1016/j.ejmech.2014.04.043 24813879
     [Google Scholar]
  68. KhanA.A. SiddiquiN. AkhtarM.J. AliZ. YarM.S. Design, synthesis, and biological evaluation of 6‐(2‐Amino‐substituted phenyl)‐4‐(substituted phenyl)‐1,2,4‐triazine‐3,5(2 H, 4 H)‐dione derivatives as anticonvulsant agents.Arch. Pharm.2016349427729210.1002/ardp.201500448 26996080
     [Google Scholar]
  69. PraskiA. JaworskaM. LodowskiP. Structure and electronic spectra of neutral and protonated forms of anticonvulsant drug lamotrigine.J. Mol. Model.20202635310.1007/s00894‑019‑4266‑2 32036441
     [Google Scholar]
  70. MallikarjunaB.P. Suresh KumarG.V. SastryB.S. Nagaraj; Manohara, K.P. Synthesis and anticonvulsant activity of some potent 5,6-bis aryl 1,2,4-triazines.J. Zhejiang Univ. Sci. B20078752653210.1631/jzus.2007.B0526 17674488
     [Google Scholar]
  71. GomhaS.M. KhalilK.D. El-ZanatyA.M. RiyadhS.M. A facile green synthesis and anti-cancer activity of bis- arylhydrazononitriles, triazolo[5,1-c][1,2,4]triazine, and 1,3,4-thiadiazolines.Heterocycles2013871109112010.3987/COM‑13‑12696
     [Google Scholar]
  72. AmirM. AliI. HassanM.Z. MulakayalaN. Design, synthesis, and biological evaluation of hydrazone incorporated 1,2,4-triazines as anticonvulsant agents.Arch. Pharm.20143471295896810.1002/ardp.201400045 25251582
     [Google Scholar]
  73. InsuastyH. CastroÉ. EscobarJ.C. MurilloV. RodríguezJ. CucaL.E. Assessment of the anticonvulsant activity of pyrazolo[1,5-a][1,3,5]triazines obtained by synthesis. Rev.Colomb Cienc Quim-Farm2014431223810.15446/rcciquifa.v43n1.45462
     [Google Scholar]
  74. ParonikyanE.G. DashyanS.S. MamyanS.S. ParonikyanR.G. NazaryanI.M. BalyanK.V. GasparyanH.V. BuloyanS.A. HunanyanL.S. HobosyanN.G. Synthesis and psychotropic properties of novel condensed triazines for drug discovery.Pharmaceuticals202417782910.3390/ph17070829 39065680
     [Google Scholar]
  75. AsadiP. AlvaniM. HajhashemiV. RostamiM. KhodarahmiG. Design, synthesis, biological evaluation, and molecular docking study on triazine based derivatives as anti-inflammatory agents.J. Mol. Struct.2021124313076010.1016/j.molstruc.2021.130760
     [Google Scholar]
  76. AshourH.M. ShaabanO.G. RizkO.H. El-AshmawyI.M. Synthesis and biological evaluation of thieno[2′,3′:4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents.Eur. J. Med. Chem.20136234135110.1016/j.ejmech.2012.12.003 23376247
     [Google Scholar]
  77. BanerjeeA.G. DasN. ShenguleS.A. SrivastavaR.S. ShrivastavaS.K. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6–diphenyl–1,2,4–triazin–3(2H)–one derivatives bearing 5–substituted 1,3,4–oxadiazole as potential anti–inflammatory and analgesic agents.Eur. J. Med. Chem.2015101819510.1016/j.ejmech.2015.06.020 26117820
     [Google Scholar]
  78. MakhloufA.A. MakladY.A. Synthesis and analgesic-anti-inflammatory activities of some 1,2,4-triazine derivatives.Drug Research2004541424910.1055/s‑0031‑1296935 14979608
     [Google Scholar]
  79. Olejarz-MaciejA. MogilskiS. KarczT. WernerT. KamińskaK. KupczykJ. Honkisz-OrzechowskaE. LataczG. StarkH. Kieć-KononowiczK. ŁażewskaD. Trisubstituted 1,3,5-triazines as histamine H 4 receptor antagonists with promising activity in vivo.Molecules20232810419910.3390/molecules28104199 37241939
     [Google Scholar]
  80. XueL. ShiD.H. HarjaniJ.R. HuangF. BeveridgeJ.G. DingjanT. BanK. DiabS. DuffyS. LucantoniL. FletcherS. ChiuF.C.K. BlundellS. EllisK. RalphS.A. WirjanataG. TeguhS. NoviyantiR. ChavchichM. CreekD. PriceR.N. MarfurtJ. CharmanS.A. CuellarM.E. StrasserJ.M. DahlinJ.L. WaltersM.A. EdsteinM.D. AveryV.M. BaellJ.B. 3,3′-disubstituted 5,5′-Bi(1,2,4-triazine) derivatives with potent in vitro and in vivo antimalarial activity.J. Med. Chem.20196252485249810.1021/acs.jmedchem.8b01799 30715882
     [Google Scholar]
  81. PathakM. OjhaH. TiwariA.K. SharmaD. SainiM. KakkarR. Design, synthesis and biological evaluation of antimalarial activity of new derivatives of 2,4,6-s-triazine.Chem. Cent. J.201711113210.1186/s13065‑017‑0362‑5 29256159
     [Google Scholar]
  82. GogoiP. ShakyaA. GhoshS.K. GogoiN. GahtoriP. SinghN. BhattacharyyaD.R. SinghU.P. BhatH.R. In silico study, synthesis, and evaluation of the antimalarial activity of hybrid dimethoxy pyrazole 1,3,5‐triazine derivatives.J. Biochem. Mol. Toxicol.2021353e2268210.1002/jbt.22682 33332673
     [Google Scholar]
  83. ManoharS. KhanS.I. RawatD.S. Synthesis, antimalarial activity and cytotoxicity of 4-aminoquinoline–triazine conjugates.Bioorg. Med. Chem. Lett.201020132232510.1016/j.bmcl.2009.10.106 19910192
     [Google Scholar]
  84. AdhikariN. KashyapA. ShakyaA. GhoshS.K. BhattacharyyaD.R. BhatH.R. SinghU.P. Microwave assisted synthesis, docking and antimalarial evaluation of hybrid PABA‐substituted 1,3,5‐triazine derivatives.J. Heterocycl. Chem.20205762389239910.1002/jhet.3955
     [Google Scholar]
  85. KimE.Y. KumarS.D. BangJ.K. ShinS.Y. Mechanisms of antimicrobial and antiendotoxin activities of a triazine‐based amphipathic polymer.Biotechnol. Bioeng.2020117113508352110.1002/bit.27499 32662872
     [Google Scholar]
  86. PatelD.H. ChikhaliaK.H. ShahN.K. PatelD.P. KaswalaP.B. BuhaV.M. Synthesis and antimicrobial studies of s -triazine based heterocycles.J. Enzyme Inhib. Med. Chem.201025112112510.3109/14756360903027956 19814592
     [Google Scholar]
  87. HaibaN.S. KhalilH.H. MoniemM.A. El-WakilM.H. BekhitA.A. KhattabS.N. Design, synthesis and molecular modeling studies of new series of s-triazine derivatives as antimicrobial agents against multi-drug resistant clinical isolates.Bioorg. Chem.20198910301310.1016/j.bioorg.2019.103013 31174040
     [Google Scholar]
  88. SalehM. AbbottS. PerronV. LauzonC. PenneyC. ZacharieB. Synthesis and antimicrobial activity of 2-fluorophenyl-4,6-disubstituted[1,3,5]triazines.Bioorg. Med. Chem. Lett.201020394594910.1016/j.bmcl.2009.12.063 20053565
     [Google Scholar]
  89. KumarA. MenonS.K. Fullerene derivatized s-triazine analogues as antimicrobial agents.Eur. J. Med. Chem.20094452178218310.1016/j.ejmech.2008.10.036 19062138
     [Google Scholar]
  90. PatelA.B. ChikhaliaK.H. KumariP. An efficient synthesis of new thiazolidin-4-one fused s-triazines as potential antimicrobial and anticancer agents.J. Saudi Chem. Soc.201418564665610.1016/j.jscs.2014.02.002
     [Google Scholar]
  91. SharmaA. GhabbourH. KhanS.T. de la TorreB.G. AlbericioF. El-FahamA. Novel pyrazolyl-s-triazine derivatives, molecular structure and antimicrobial activity.J. Mol. Struct.2017114524425310.1016/j.molstruc.2017.05.040
     [Google Scholar]
  92. DinariM. GharahiF. AsadiP. Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine-quinazolinone based hybrids.J. Mol. Struct.20181156435010.1016/j.molstruc.2017.11.087
     [Google Scholar]
  93. ShanmugamM. NarayananK. ChidambaranathanV. KabilanS. Synthesis, spectral characterization and antimicrobial studies of novel s-triazine derivatives.Spectrochim. Acta A Mol. Biomol. Spectrosc.201310538339010.1016/j.saa.2012.12.046 23333692
     [Google Scholar]
  94. PatelA.B. PatelR.V. KumariP. RajaniD.P. ChikhaliaK.H. Synthesis of potential antitubercular and antimicrobial s-triazine-based scaffolds via Suzuki cross-coupling reaction.Med. Chem. Res.201322136738110.1007/s00044‑012‑0041‑y
     [Google Scholar]
  95. MorenoL.M. QuirogaJ. AboniaR. CrespoM.P. AranagaC. Martínez-MartínezL. SortinoM. BarretoM. BurbanoM.E. InsuastyB. Synthesis of novel triazine-based chalcones and 8,9-dihydro-7 H-pyrimido[4,5-b][1,4]diazepines as potential leads in the search of anticancer, antibacterial and antifungal agents.Int. J. Mol. Sci.2024257362310.3390/ijms25073623 38612435
     [Google Scholar]
  96. MaliszewskiD. DemirelR. WróbelA. BaradynM. RatkiewiczA. DrozdowskaD. s-Triazine derivatives functionalized with alkylating 2-chloroethylamine fragments as promising antimicrobial agents: Inhibition of bacterial DNA gyrases, molecular docking studies, and antibacterial and antifungal activity.Pharmaceuticals2023169124810.3390/ph16091248 37765056
     [Google Scholar]
  97. El MalahT. NourH.F. NaylA.A. ElkhashabR.A. Abdel-MegeidF.M.E. AliM.M. Anticancer evaluation of tris(triazolyl)triazine Derivatives generated via click chemistry.Aust. J. Chem.201669890591010.1071/CH16006
     [Google Scholar]
  98. El-WakilM.H. KhattabS.N. El-YazbiA.F. El-NikhelyN. SoffarA. KhalilH.H. New chalcone-tethered 1,3,5-triazines potentiate the anticancer effect of cisplatin against human lung adenocarcinoma A549 cells by enhancing DNA damage and cell apoptosis.Bioorg. Chem.202010510439310.1016/j.bioorg.2020.104393 33120322
     [Google Scholar]
  99. KothayerH. SpencerS.M. TripathiK. WestwellA.D. PalleK. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.Bioorg. Med. Chem. Lett.20162682030203410.1016/j.bmcl.2016.02.085 26965855
     [Google Scholar]
  100. SączewskiF. BułakowskaA. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.Eur. J. Med. Chem.200641561161510.1016/j.ejmech.2005.12.012 16540207
     [Google Scholar]
  101. El-FahamA. FarooqM. AlmarhoonZ. AlhameedR.A. WadaanM.A.M. de la TorreB.G. AlbericioF. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.Bioorg. Chem.20209410339710.1016/j.bioorg.2019.103397 31706684
     [Google Scholar]
  102. FarooqM. SharmaA. AlmarhoonZ. Al-DhfyanA. El-FahamA. TahaN.A. WadaanM.A.M. TorreB.G. AlbericioF. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.Bioorg. Chem.20198745746410.1016/j.bioorg.2019.03.063 30927586
     [Google Scholar]
  103. SinglaP. LuxamiV. PaulK. Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin.Eur. J. Med. Chem.2016117596910.1016/j.ejmech.2016.03.088 27089212
     [Google Scholar]
  104. Jagadeesh KumarG. Sriramkumar BommaH.V.S. SrihariE. ShrivastavaS. NaiduV.G.M. SrinivasK. Jayathirtha RaoV. Synthesis and anticancer activity of some new s-triazine derivatives.Med. Chem. Res.201322125973598110.1007/s00044‑013‑0584‑6
     [Google Scholar]
  105. SinglaP. LuxamiV. PaulK. Triazine–benzimidazole hybrids: Anticancer activity, DNA interaction and dihydrofolate reductase inhibitors.Bioorg. Med. Chem.20152381691170010.1016/j.bmc.2015.03.012 25792141
     [Google Scholar]
  106. ElmorsyM.R. Abdel-LatifE. GafferH.E. MahmoudS.E. FaddaA.A. Anticancer evaluation and molecular docking of new pyridopyrazolo-triazine and pyridopyrazolo-triazole derivatives.Sci. Rep.2023131278210.1038/s41598‑023‑29908‑y 36797448
     [Google Scholar]
  107. ChupakhinO.N. CharushinV.N. RusinovV.L. Scientific foundations for the creation of antiviral and antibacterial preparations.Herald Russ. Acad. Sci.201686320621210.1134/S1019331616030163
     [Google Scholar]
  108. SumotoK. MibuN. YokomizoK. YuzurihaA. OtsuboM. KawaguchiY. SanoM. SakaiI. NakayamaK. ZhouJ-R. Antiviral activities of some new 2,4,6-trisubstituted 1,3,5-triazines having alkoxy and/or alkylamino groups.Heterocycles20179491653167710.3987/COM‑17‑13735
     [Google Scholar]
  109. MibuN. YokomizoK. KogaA. HondaM. MizokamiK. FujiiH. Synthesis and antiviral activities of some 2,4,6-trisubstituted 1,3,5-triazines.Chem. Pharm. Bull.201462101032104010.1248/cpb.c14‑00421 25273062
     [Google Scholar]
  110. MibuN. YokomizoK. AkiH. OtaN. FujiiH. Yuzuriha, A Synthesis and antiviral evaluation of some C(3)-symmetrical trialkoxy-substituted 1,3,5-triazines and their molecular geometry.Chem. Pharm. Bull.2015631193594410.1248/cpb.c16‑e6403 26521858
     [Google Scholar]
  111. KhodairA.I. El-BarbaryA.A. ImamD.R. KhederN.A. ElmalkiF. Ben HaddaT. Synthesis, antiviral, DFT and molecular docking studies of some novel 1,2,4-triazine nucleosides as potential bioactive compounds.Carbohydr. Res.202150010824610.1016/j.carres.2021.108246 33516074
     [Google Scholar]
  112. ShabuninaO.V. ShtaitzY.K. KopchukD.S. KrinochkinA.P. SantraS. ZyryanovG.V. WangZ. RusinovV.L. ChupakhinO.N. Synthesis of novel 3-(Pyridin-4-yl)-1,2,4-Triazines, their analogs and study of the activity against vaccinia virus.Chem. Heterocycl. Compd.202157446246610.1007/s10593‑021‑02924‑4
     [Google Scholar]
  113. ShamimS. KhanK.M. UllahN. ChigurupatiS. WadoodA. Ur RehmanA. AliM. SalarU. AlhowailA. TahaM. PerveenS. Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase.Bioorg. Chem.202010110397910.1016/j.bioorg.2020.103979 32544738
     [Google Scholar]
  114. WangY. TangX. YiL. Design and discovery of novel 1,3,5-triazines as dipeptidyl peptidase-4 inhibitor against diabetes.Pharmacology20191035-627328110.1159/000494060 30799431
     [Google Scholar]
  115. GaoH-D. LiuP. YangY. GaoF. Sulfonamide-1,3,5-triazine–thiazoles: Discovery of a novel class of antidiabetic agents via inhibition of DPP-4.RSC Advances2016686834388344710.1039/C6RA15948F
     [Google Scholar]
  116. RusinovV.L. SapozhnikovaI.M. BliznikA.M. ChupakhinO.N. CharushinV.N. SpasovA.A. VassilievP.M. KuznetsovaV.A. RashchenkoA.I. BabkovD.A. Synthesis and evaluation of novel[1,2,4]Triazolo[5,1‐ c][1,2,4]‐triazines and pyrazolo[5,1‐ c][1,2,4]triazines as potential antidiabetic agents.Arch. Pharm.20173505160036110.1002/ardp.201600361 28393419
     [Google Scholar]
  117. GuertinK.R. SettiL. QiL. DunsdonR.M. DymockB.W. JonesP.S. OvertonH. TaylorM. WilliamsG. SergiJ.A. WangK. PengY. RenzettiM. BoyceR. FalcioniF. GarippaR. OlivierA.R. Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity.Bioorg. Med. Chem. Lett.200313172895289810.1016/S0960‑894X(03)00623‑1 14611852
     [Google Scholar]
  118. ValipourM. Zakeri KhatirZ. KiadaliryK. MojtabaviS. FaramarziM.A. SayyadM.S. SeyedabadiM. GhasemianM. HashemiS.M. IrannejadH. Design, synthesis, α-glucosidase inhibition and hypoglycemic activity of 3-aceto(benzo)hydrazide-1,2,4-triazines as potential anti-diabetic agents.Eur. J. Med. Chem. Rep.20241210020710.1016/j.ejmcr.2024.100207
     [Google Scholar]
  119. IrajiA. FiruziO. KhoshneviszadehM. NadriH. EdrakiN. MiriR. Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer’s disease.Bioorg. Chem.20187722323510.1016/j.bioorg.2018.01.017 29367079
     [Google Scholar]
  120. MaqboolM. ManralA. JameelE. KumarJ. SainiV. ShandilyaA. TiwariM. HodaN. JayaramB. Development of cyanopyridine–triazine hybrids as lead multitarget anti-Alzheimer agents.Bioorg. Med. Chem.201624122777278810.1016/j.bmc.2016.04.041 27157006
     [Google Scholar]
  121. YazdaniM. EdrakiN. BadriR. KhoshneviszadehM. IrajiA. FiruziO. Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: Design, synthesis and biological evaluation.Bioorg. Chem.20198436337110.1016/j.bioorg.2018.11.038 30530107
     [Google Scholar]
  122. YazdaniM. EdrakiN. BadriR. KhoshneviszadehM. IrajiA. FiruziO. 5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer’s disease modifying agents.Mol. Divers.202024364165410.1007/s11030‑019‑09970‑3 31327094
     [Google Scholar]
  123. JameelE. MeenaP. MaqboolM. KumarJ. AhmedW. MumtazuddinS. TiwariM. HodaN. JayaramB. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.Eur. J. Med. Chem.2017136365110.1016/j.ejmech.2017.04.064 28478343
     [Google Scholar]
  124. Sudoł-TałajS. Kucwaj-BryszK. PodlewskaS. KurczabR. SatałaG. MordylB. Głuch-LutwinM. Wilczyńska-ZawalN. Jastrzębska-WięsekM. Czarnota-ŁydkaK. KurowskaK. KubackaM. ŻesławskaE. NitekW. Olejarz-MaciejA. Doroz-PłonkaA. PartykaA. LataczG. WesołowskaA. HandzlikJ. Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer’s disease for potent serotonin 5-HT6R agents.Eur. J. Med. Chem.202326011575610.1016/j.ejmech.2023.115756 37657272
     [Google Scholar]
  125. Al-TrawnehS.A. Al-DawdiehS.A. AbutalebN.S. TarawnehA.H. SalamaE.A. El-AbadelahM.M. Synthesis of new pyrazolo[5,1-c][1,2,4]triazines with antifungal and antibiofilm activities.Chem. Pap.20197421241125210.1007/s11696‑019‑00974‑9
     [Google Scholar]
  126. Abdel-GalilE. ArabA.M. AfsahE.M. Synthesis and biological activity evaluation of some new mixed azines appended tetrahydro-1,2,4-triazines.Synth. Commun.20215191373138310.1080/00397911.2021.1882497
     [Google Scholar]
  127. DingZ. NiT. XieF. HaoY. YuS. ChaiX. JinY. WangT. JiangY. ZhangD. Design, synthesis, and structure-activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus.Bioorg. Med. Chem. Lett.202030412695110.1016/j.bmcl.2020.126951 31926784
     [Google Scholar]
  128. MasihA. ShrivastavaJ.K. BhatH.R. SinghU.P. Potent antibacterial activity of dihydydropyrimidine‐1,3,5‐triazines via inhibition of DNA gyrase and antifungal activity with favourable metabolic profile.Chem. Biol. Drug Des.202096286186910.1111/cbdd.13695 32333828
     [Google Scholar]
/content/journals/coc/10.2174/0113852728379266250708074432
Loading
Triazines as Versatile Scaffolds in Drug Discovery: A Comprehensive Review on Recent Advances and Emerging Therapeutic Applications
Current Organic Chemistry 30, 409 (2026); https://doi.org/10.2174/0113852728379266250708074432
/content/journals/coc/10.2174/0113852728379266250708074432
/content/journals/coc/10.2174/0113852728379266250708074432
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): anticancer; anticonvulsant; antidiabetic; antimicrobial; microwave synthesis; Triazine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test